The picture is mixed. Providers heavily dependent on Medicare continue to see policy and reimbursement headwinds. For them, DVA is the canary in the coal mine. The dialysis business has become so fragile, all it took was a SCOTUS decision on commercial plan design to send the stock price - after billions in buybacks - down almost 15%. The worst is not likely to be over. DVA's call this morning was not exactly...convincing.
Others, with a more balanced mix of revenue streams appear to be functioning normally. #Quad4 and a recession likely is still not cutting loose enough low wage/low skill workers to matter. Access, the federal government's primary concern, is showing its limits. Mortality, a good indicator of overall health, suggests demand is high but supply limited.
We will run through all the numbers as we tee it up for 2Q earnings.
|
Connection Details. Thursday, June 23 @ 10 am ET (add to Outlook Calendar) CLICK HERE for event details (includes video and materials link) (Cut and paste of uncooperative browsers: https://app.hedgeye.com/feed_items/118181?with_category=48-health-policy) Live video only 30 min format with Q & A if time allows. |
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn